These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
856 related articles for article (PubMed ID: 28867370)
21. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. Das S; Ghosh S; De AK; Bera T Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178 [TBL] [Abstract][Full Text] [Related]
22. Augmented ocular uptake and anti-inflammatory efficacy of decorated Genistein-loaded NLCs incorporated in in situ gel. Elmanawy MA; Boraie N; Bakr BA; Makled S Int J Pharm; 2024 Sep; 662():124508. PubMed ID: 39053680 [TBL] [Abstract][Full Text] [Related]
23. Penetration of Nile red-loaded nanostructured lipid carriers (NLCs) across the porcine cornea. Niamprem P; Srinivas SP; Tiyaboonchai W Colloids Surf B Biointerfaces; 2019 Apr; 176():371-378. PubMed ID: 30658285 [TBL] [Abstract][Full Text] [Related]
24. The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin. Malgarim Cordenonsi L; Faccendini A; Catanzaro M; Bonferoni MC; Rossi S; Malavasi L; Platcheck Raffin R; Scherman Schapoval EE; Lanni C; Sandri G; Ferrari F Int J Pharm; 2019 Aug; 567():118487. PubMed ID: 31271813 [TBL] [Abstract][Full Text] [Related]
25. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions. Zhang W; Li X; Ye T; Chen F; Yu S; Chen J; Yang X; Yang N; Zhang J; Liu J; Pan W; Kong J Int J Nanomedicine; 2014; 9():4305-15. PubMed ID: 25246787 [TBL] [Abstract][Full Text] [Related]
26. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555 [TBL] [Abstract][Full Text] [Related]
27. Formulation Development, Optimization, and In Vitro-In Vivo Characterization of Natamycin-Loaded PEGylated Nano-Lipid Carriers for Ocular Applications. Patil A; Lakhani P; Taskar P; Wu KW; Sweeney C; Avula B; Wang YH; Khan IA; Majumdar S J Pharm Sci; 2018 Aug; 107(8):2160-2171. PubMed ID: 29698725 [TBL] [Abstract][Full Text] [Related]
28. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496 [TBL] [Abstract][Full Text] [Related]
29. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987 [TBL] [Abstract][Full Text] [Related]
30. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution. Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499 [TBL] [Abstract][Full Text] [Related]
31. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism. Sun X; Sheng Y; Li K; Sai S; Feng J; Li Y; Zhang J; Han J; Tian B Acta Biomater; 2022 Jan; 138():193-207. PubMed ID: 34757228 [TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
33. N-acetylcysteine functionalized chitosan oligosaccharide-palmitic acid conjugate enhances ophthalmic delivery of flurbiprofen and its mechanisms. Sheng Y; Sun X; Han J; Hong W; Feng J; Xie S; Li Y; Yan F; Li K; Tian B Carbohydr Polym; 2022 Sep; 291():119552. PubMed ID: 35698331 [TBL] [Abstract][Full Text] [Related]
34. Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Üstündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ertan G; Özer Ö Expert Opin Drug Deliv; 2015; 12(11):1791-807. PubMed ID: 26159181 [TBL] [Abstract][Full Text] [Related]
35. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119 [TBL] [Abstract][Full Text] [Related]
36. Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier. Yostawonkul J; Surassmo S; Iempridee T; Pimtong W; Suktham K; Sajomsang W; Gonil P; Ruktanonchai UR Colloids Surf B Biointerfaces; 2017 Jan; 149():301-311. PubMed ID: 27780087 [TBL] [Abstract][Full Text] [Related]
37. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994 [TBL] [Abstract][Full Text] [Related]